Article thumbnail

Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis

By Henning W. Zimmermann, Sebastian Seidler, Jacob Nattermann, Nikolaus Gassler, Claus Hellerbrand, Alma Zernecke, Jens J. W. Tischendorf, Tom Luedde, Ralf Weiskirchen, Christian Trautwein and Frank Tacke
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2883575
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.
  2. (2003). Blood monocytes consist of two principal subsets with distinct migratory properties.
  3. (2009). Blood monocytes: development, heterogeneity, and relationship with dendritic cells.
  4. (2005). Blood platelet and monocyte activations and relation to stages of liver cirrhosis.
  5. (2010). Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.
  6. (2007). Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.
  7. (2009). CCR1 and CCR5 promote hepatic fibrosis in mice.
  8. (2009). CCR2 promotes hepatic fibrosis in mice.
  9. (2007). CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.
  10. (2008). Chemokinedirected immune cell infiltration in acute and chronic liver disease.
  11. (1994). Classification of chronic hepatitis: diagnosis, grading and staging.
  12. (2010). Comparison of gene expression profiles between human and mouse monocyte subsets.
  13. (2007). Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.
  14. (2006). Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
  15. (2009). Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.
  16. (2007). Endotoxemia contributes to the immune paralysis in patients with cirrhosis.
  17. (1996). Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells.
  18. (2007). Gene expression profiles during hepatic stellate cell activation in culture and in vivo.
  19. (2003). Ghrelin in chronic liver disease.
  20. (2009). Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
  21. (2003). Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration.
  22. (1998). Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
  23. (2007). Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages.
  24. (2006). MCP-1/ CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes.
  25. (2006). Migratory fate and differentiation of blood monocyte subsets.
  26. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.
  27. (2005). Monocyte and macrophage heterogeneity.
  28. (2007). Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.
  29. (2009). Monocytes and macrophages as cellular targets in liver fibrosis.
  30. (2007). Mouse models of liver fibrosis.
  31. (2005). Patients with acute on chronic liver failure display ‘‘sepsis-like’’ immune paralysis.
  32. (2005). Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.
  33. (2009). Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
  34. (2005). Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.
  35. (2007). The CD14+ CD16+ blood monocytes: their role in infection and inflammation.
  36. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis.
  37. (2003). TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.